Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Korean Journal of Pediatric Infectious Diseases ; : 31-39, 2011.
Article in Korean | WPRIM | ID: wpr-217566

ABSTRACT

PURPOSE: This study was performed for the purpose of finding causative organisms and clinical features of septic arthritis or acute osteomyelitis in children. METHODS: The study involved a retrospective review of the medical records of 63 microbiologically confirmed cases of acute pyogenic arthritis and osteomyelitis. All of the cases were brought about by community-associated infections and managed at the Seoul National University Children's Hospital or Seoul National University Bundang Hospital from June 2003 to July 2009. RESULTS: The median age of all cases was 60 months and there were 35 males and 28 females. Major involved joints included the hip joint (15 cases), knee joint (7 cases), shoulder joint (4 cases), and elbow joint (4 cases). Also, major involved bones included the femur (20 cases), tibia (13 cases), humerus (7 cases), and radius (7 cases). Staphylococcus aureus was the most commonly identified causative organism, accounting for 49 cases (77.8%). Of the 49 isolates of S. aureus, methicillin-resistant S. aureus (MRSA) accounted for 8 cases (16.3%). Group B streptococcus spp. (GBS) and Salmonella spp. accounted for 3 cases, respectively. Nafcillin or cefazolin was often prescribed as an initial empirical antibiotic. There were 9 cases that were managed by a regimen that included vancomycin as the first choice. Fifty four cases (85.7%) recovered without any complications. Methicillin-sensitive S. aureus (MSSA), responsible for 41 cases, caused chronic complications in 3 cases. Of 8 cases caused by MRSA, 1 case showed chronic complication. There were no fatal cases. CONCLUSION: S. aureus remains the most common organism causing acute pyogenic arthritis and osteomyelitis of childhood acquired in the community. The high prevalence of methicillin resistance among S. aureus should be considered carefully in the selection of initial empirical antibiotics.


Subject(s)
Child , Female , Humans , Male , Accounting , Anti-Bacterial Agents , Arthritis , Arthritis, Infectious , Cefazolin , Elbow Joint , Femur , Hip Joint , Humerus , Joints , Knee Joint , Medical Records , Methicillin Resistance , Methicillin-Resistant Staphylococcus aureus , Nafcillin , Osteoarthritis , Osteomyelitis , Prevalence , Radius , Retrospective Studies , Salmonella , Shoulder Joint , Staphylococcus aureus , Streptococcus , Tibia , Vancomycin
2.
Korean Journal of Pediatrics ; : 1000-1005, 2010.
Article in English | WPRIM | ID: wpr-227773

ABSTRACT

PURPOSE: This study aimed to determine the optimal initial vancomycin dose to achieve appropriate trough levels in pediatric patients. METHODS: We analyzed clinical data for 309 children treated with intravenous vancomycin between 2004 and 2009 at 2 different hospitals in South Korea. The patients were 1-16 years old and exhibited normal renal function. Patient data, including reason for treatment and initial dosing regimen, were reviewed. Two subgroups were identified and compared according to initial vancomycin dose: 40 (35-45) mg/kg/day and 60 (55-65) mg/kg/day. Trough levels were obtained at steady state after at least 4 doses of vancomycin. RESULTS: Patients who received vancomycin had post-operation or wound-related infections (37.2%), localized infection (12.9%), catheter-related infections (9.4%), meningitis (8.7%), or endocarditis (6.8%). Pathogens were confirmed in 79 cases: 28 cases of methicillin-resistant Staphylococcus epidermidis (35.4%) and 25 of methicillin-resistant Staphylococcus aureus (31.6%). Out of the 309 patients, 201 (65%) received vancomycin at 40 mg/kg/day and 108 (35%) at 60 mg/kg/day. Average trough concentrations were significantly different between the groups (P<0.001). Trough levels over 10 mg/L were less likely to be achieved in the 40 mg/kg/day group (14%) than in the 60 mg/kg/day group (49%) (P<0.001). There were no differences in renal function deterioration between the groups. CONCLUSION: A common vancomycin dosing regimen, 40 mg/kg/day, was not high enough to achieve trough levels of over 10 mg/L in pediatric patients. Careful drug monitoring must be performed, and increasing initial dose of vancomycin should be considered in pediatric patients.


Subject(s)
Child , Humans , Catheter-Related Infections , Drug Monitoring , Endocarditis , Meningitis , Methicillin Resistance , Methicillin-Resistant Staphylococcus aureus , Republic of Korea , Staphylococcus epidermidis , Vancomycin
3.
Korean Journal of Pediatric Infectious Diseases ; : 205-209, 2009.
Article in Korean | WPRIM | ID: wpr-55869

ABSTRACT

Staphylococcal toxic shock syndrome (TSS) is a severe systemic illness caused by toxins produced by Staphylococcus aureus. We report a case of staphylococcal TSS in a 16 month-old boy who presented with high fever, vomiting, skin rash, and shock after a burn injury. He was managed with intravenous vancomycin, fresh frozen plasma, and intravenous immunoglobulin. Methicillin-resistant S. aureus (MRSA) was isolated from the burn wound site and anterior nostril of the patient. In addition, the MRSA isolate was genetically characterized.


Subject(s)
Humans , Burns , Exanthema , Fever , Immunoglobulins , Methicillin Resistance , Methicillin-Resistant Staphylococcus aureus , Plasma , Shock , Shock, Septic , Staphylococcus aureus , Vancomycin , Vomiting
4.
Korean Journal of Pediatric Infectious Diseases ; : 92-96, 2009.
Article in Korean | WPRIM | ID: wpr-163702

ABSTRACT

Mycoplasma pneumoniae is a common cause of respiratory tract infections. And M. pneumoniae infection frequently manifests with extrapulmonary symptoms such as central nervous system complications, skin or mucosal involvement, and gastrointestinal problems. However, cardiac complications associated with M. pneumoniae are rarely reported. We report the case of a 47-month-old girl who died of fulminant myocarditis associated with M. pneumoniae pneumonia.


Subject(s)
Central Nervous System , Mycoplasma , Mycoplasma pneumoniae , Myocarditis , Pneumonia , Pneumonia, Mycoplasma , Child, Preschool , Respiratory Tract Infections , Skin
SELECTION OF CITATIONS
SEARCH DETAIL